Header

In the News

30 May 2014 | Reuters

Lionel Melka on European M&A

Big merger flops may stall Europe's stock market rally

"We are at the start of a new M&A cycle ... The problem today is that I would say deals are taking much longer than before to be finalised," Lionel Melka, a partner at Paris-based fund Bernheim Dreyfus, which bets on merger activity, said.

15 May 2014 | L\'Agefi

Lionel Melka on the current M&A activity

Multinationales, la localisation en jeu

« Le cas AstraZeneca-Pfizer (comme déjà le deal Elan-Perrigo en Irlande) montre une évolution historique, estime Lionel Melka.

18 Feb 2014 | FT

Lionel Melka on Actavis/Forest Labs

Actavis buys Forest Laboratories for $25bn

Lionel Melka, head of research at Paris-based M&A hedge fund Bernheim, Dreyfus said: “Actavis’ offer is a big surprise because the market was expecting AstraZeneca to make an offer. It is not impossible that another buyer will emerge.”

09 Jan 2014 | L\'Agefi

Lionel Melka on the 2014 M&A outlook

Les premiers signes d’une reprise

"La hausse des marchés actionsa, comme toujours, accéléré le passage à l’acte, d’autant plusque les cours de Bourse des acquéreurs réagissent positivement aux annonces, ajoute Lionel Melka,..."

|  2 |  10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34